Company Filing History:
1 out of 32 
1 out of 7 
1 out of 155 
Years Active: 2022
Title: Innovations in Tryptophan Measurement: The Contributions of Sasa Koncarevic
Introduction: Sasa Koncarevic, an inventor based in Sennfeld, Germany, has made significant strides in the field of biochemistry, especially regarding the measurement of tryptophan and its metabolites. With a keen understanding of metabolic pathways, his work focuses on the crucial role of tryptophan degradation in immune reactions, particularly in the context of cancer progression.
Latest Patents: Sasa Koncarevic holds a patent titled "Isotopic methods for measurement of tryptophan and metabolites thereof." This innovation outlines methods for measuring mass tag labelled tryptophan and its metabolites. The patent highlights the importance of these measurements in monitoring treatment effectiveness, diagnosing immune response suppression, and stratifying patients for personalized care. The invention addresses the pressing need to understand how tryptophan metabolites contribute to immune escape in cancer cells.
Career Highlights: Throughout his career, Sasa Koncarevic has worked with esteemed organizations that have enriched his research experience. Notable among these is Electrophoretics Limited, where he likely gained valuable insights into biophysical methods. In addition, his tenure at Ruprecht-Karls-Universität afforded him opportunities to collaborate with leading researchers in the field.
Collaborations: Sasa has collaborated with notable colleagues, including Karsten Kuhn and Peter Schulz-Knappe. These partnerships have facilitated innovative research and further advancement in understanding the biochemical pathways associated with tryptophan metabolism and its implications for cancer treatment.
Conclusion: Sasa Koncarevic's groundbreaking work on tryptophan measurement exemplifies the impact of innovation in the medical field. His patent not only provides new methodologies for studying immune responses but also underscores the importance of tailored treatments in combating cancer. As researchers continue to build upon his contributions, the potential for improving patient outcomes through better understanding of tryptophan metabolism remains promising.